Intermittent calorie restriction has been shown to improve executive function and memory in cognitively intact older adults, according to an exploratory pilot study. The study, which involved 40 overweight, cognitively normal older adults with insulin resistance, compared the effects of a 5:2 intermittent fasting plan with a “healthy living” diet based on portion control and
Health
Recently, the Genetic Metabolic Diseases Advisory Committee voted 11-5 in favor of the investigational treatment arimoclomol for Niemann-Pick disease type C. This decision was based on the totality of clinical and nonclinical data, as well as the favorable safety profile of the drug. If the FDA ultimately approves arimoclomol, it will be the first treatment
The Food and Drug Administration (FDA) recently granted accelerated approval to afamitresgene autoleucel (afami-cel, Tecelra) as a treatment for advanced synovial sarcoma. This marks a significant milestone as it is the first engineered cell therapy approved for a solid tumor. Afami-cel is an autologous T-cell immunotherapy specifically indicated for adults with unresectable or metastatic disease
Recent research has revealed a concerning link between traces of non-essential and essential metals in urine and an increased risk of cardiovascular disease (CVD) and all-cause mortality. The largest epidemiological study on the topic, based on the Multi-Ethnic Study of Atherosclerosis (MESA), has shed light on the association between individual urinary metals and incident events
The recent release of CMS’s proposed Medicare fee schedule for physicians and healthcare professionals in 2025 has created waves in the healthcare industry. One of the key points of contention is the significant decrease in the Medicare “conversion factor” (CF), which plays a crucial role in determining payment rates for services and procedures. The proposed
North Carolina Governor Roy Cooper’s administration recently received approval from the Centers for Medicare & Medicaid Services (CMS) for a groundbreaking proposal aimed at helping hospitals in the state eliminate patients’ medical debt. This new initiative has the potential to impact millions of low- and middle-income residents in North Carolina by alleviating a significant amount
The recent FDA approval of the Shield blood test for colorectal cancer (CRC) screening in adults ages 45 and older at average risk has been a significant breakthrough in the field of cancer detection. This approval makes Shield the first blood test to be approved as a primary screening option for CRC, offering a compelling
The world is currently facing an unprecedented threat from dengue fever, a mosquito-borne virus that has rapidly spread across the globe. According to recent reports from the CDC, the number of reported cases of dengue in the Americas has doubled this year, reaching a staggering 9.7 million cases by June 24. This alarming increase in
The potential approval of MDMA for post-traumatic stress disorder (PTSD) treatment has sparked controversy within the psychedelic community. The VA’s Under-Secretary for Health, Dr. Shereff Elnahal, expressed support for the use of MDMA to treat PTSD at a New York conference, highlighting the groundbreaking research conducted by MAPS. However, the FDA advisory committee voted against
Recent research has challenged preconceived notions about the behavior of the H5N1 bird flu in cattle, shedding light on the severity of the illness and the potential for asymptomatic animals to spread the disease. These findings have significant implications for both animal and human health, emphasizing the importance of robust measures to prevent and control